Advertisement

Topics

Focal Therapeutics Company Profile

20:28 EDT 23rd September 2018 | BioPortfolio

Focal Therapeutics is a medical device company based in Silicon Valley. The company’s first product is the BioZorb™ tissue marker, a bioabsorbable device that provides radiographic marking of soft tissue sites. The BioZorb device is placed at the time of surgical removal of tissue, such as during breast surgery, and the device’s three-dimensional array of marker elements has utility for clinical imaging. Focal Therapeutics is led by a seasoned team with a proven track record in the successful development and commercialization of medical products.


News Articles [768 Associated News Articles listed on BioPortfolio]

EDAP Announces FDA Clearance for Focal One

EDAP (Nasdaq: EDAP) the global leader in therapeutic ultrasound, today announced that it has received 510(k) clearance from the US Food and Drug Administration (FDA) for its Focal One device for the a...

PROM microscopy analyses cellular focal adhesion dynamics

Researchers have developed a new form of microscopy that allows them to observe the formation and evolution of cell membrane focal adhesions... The post

Study offers possibility of squelching a focal epilepsy seizure before symptoms appear

Patients with focal epilepsy that does not respond to medications badly need alternative treatments.

Automated detection of focal epileptic seizures in a sentinel area of the human brain

(University of Alabama at Birmingham) In a first-in-humans pilot study, researchers have identified a sentinel area of the brain that may give an early warning before clinical seizure manifestations f...

Researchers develop novel microscopy to observe cellular focal adhesion dynamics

Focal adhesions are large specialized proteins that are located in the area where a cell membrane meets the extracellular matrix, a collection of molecules surrounding the cells that provide support a...

Novel Focal Therapy Treatment Options for Prostate Cancer

Find out what there is to know about novel prostate cancer focal therapy strategies. Current Opinion in Urology

Focal Adhesion Kinase FAK Inhibitor Pipeline Insight, 2018 [Report Updated: 14022018] Prices from USD $1250

Focal Adhesion Kinase FAK Inhibitor Pipeline Insight, 2018 report by DelveInsight offers comprehensive insights of the pipeline under development therapeutics scenario and growth prospects across Foc...

Viral vector based gene therapies show promise for treating focal epilepsy [PreClinical]

1. Seizures are often associated with accumulation of extracellular glutamate due to the synchronous discharges of excitatory neurons. 2. Treatment of rats with a lentiviral plasmid encoding a glutama...

PubMed Articles [771 Associated PubMed Articles listed on BioPortfolio]

Controllable long focal length microlens based on thermal expansion.

A novel method to fabricate a microlens array with a long focal length has been developed in this paper. It is based on the fabricating and heating of a microlens consisting of two materials with a gr...

Prediction of secondary generalization from a focal onset seizure in intracerebral EEG.

We propose a system based on the first five seconds of intracerebrally recorded focal seizures to predict their evolution from focal to bilateral tonic-clonic seizure (FTC), to spread outside the onse...

DEPDC5 takes a second hit in familial focal epilepsy.

Loss-of-function mutations in a single allele of the gene encoding DEP domain-containing 5 protein (DEPDC5) are commonly linked to familial focal epilepsy with variable foci; however, a subset of pati...

Magnetic resonance imaging features of common focal liver lesions in children.

Magnetic resonance imaging (MRI) is commonly used to characterize focal liver masses in the pediatric population. MRI is the preferred modality because of its superior contrast resolution and utility ...

Stereotactic Selective Thalamotomy for Focal Dystonia with Aid of Depth Microrecording.

Long-term effectiveness of selective ventralis intermedius (VIM)-ventralis oralis (VO) thalamotomy with depth microrecording for the treatment of focal dystonia was evaluated. The optimal thalamic are...

Clinical Trials [530 Associated Clinical Trials listed on BioPortfolio]

Genetic and Electrophysiologic Study in Focal Drug-resistant Epilepsies

Genetic abnormalities in focal epilepsies are well known. A novel gene (DEPDC5) was identified, associated with various genotypes of epilepsies. Recently, DEPDC5 mutations were identified ...

Evaluation of Focal Treatments of Localized Prostate Cancers With High Intensity Focused Ultrasound Using the Focal One® Device

Focal treatment of localized prostate cancer aims to destroy the cancerous foci without damaging surrounding tissues to avoid the side effects of radical treatments. This is why focal trea...

Stem Cell Therapy for Patients With Focal Segmental Glomerulosclerosis

The purpose of this study is to analyze the safety, renal function, metabolic disorders and quality of life data in patients with focal segmental glomerulosclerosis treated with endovascul...

Survey of Sensory and Motor Tricks in Focal Dystonia

This study will collect information on (tricks) patients with focal dystonia use to relieve their symptoms. Dystonia is a movement disorder caused by sustained muscle contractions often c...

Human Epilepsy Project 2: Resistant Focal Seizures Study

The HEP2 study is designed to better understand the challenges of living with focal seizures that do not respond to medication, by following 200 people with medication-resistant focal epil...

Companies [1282 Associated Companies listed on BioPortfolio]

Focal Therapeutics

Focal Therapeutics is a medical device company based in Silicon Valley. The company’s first product is the BioZorb™ tissue marker, a bioabsorbable device that provides r...

Focal Pointe Data Solutions

Headquartered in Carlsbad, Calif., Focal Pointe Data Solutions, LLC is a service technology company providing data management, analytics and business intelligence solutions for ho...

Aeris Therapeutics

Aeris Therapeutics is an emerging medical therapeutics company specializing in the development and commercialization of novel treatments for patients with emphysema and other adva...

Altair Therapeutics, Inc.

Based in San Diego, Altair Therapeutics, Inc. is a privately-held biopharmaceutical company developing novel therapeutics to treat human respiratory diseases. Altair Therap...

Vaxiion Therapeutics, Inc.

Vaxiion is dedicated to the design and development of intelligent drug-delivery technologies with special emphasis on targeted oncology therapeutics. Vaxiion Therapeutics was spun...

More Information about "Focal Therapeutics" on BioPortfolio

We have published hundreds of Focal Therapeutics news stories on BioPortfolio along with dozens of Focal Therapeutics Clinical Trials and PubMed Articles about Focal Therapeutics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Focal Therapeutics Companies in our database. You can also find out about relevant Focal Therapeutics Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...

Breast Cancer
Track and monitor developments in breast cancer research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on breast cancer and follow companies active in the development of breast cancer tr...


Corporate Database Quicklinks



Searches Linking to this Company Record